U.S. Biotech Stock News

What Equifax’s recent share performance tells you Equifax (EFX) has seen its share price under pressure, with a 12.5% decline year to date and a 19.8% total return decline over the past year, prompting closer attention from investors. Over the past month, the stock shows a 2.8% decline, widening to a 14.1% total return decline over the past 3 months. These moves contrast with longer term returns, where the past 5 years show a 10.7% total return gain. See our latest analysis for Equifax. At a...

In recent weeks, Permian Resources increased its quarterly dividend and saw a sharp reduction in short interest, while analysts highlighted the company’s free cash flow potential amid ongoing Middle East tensions. Together, these developments point to growing confidence in Permian Resources’ ability to generate cash and return capital, even as geopolitical risks keep energy markets on edge. Next, we’ll examine how the higher dividend and shifting short interest influence Permian Resources’...

DENTSPLY SIRONA (XRAY) shares are in focus after the company and Siemens Healthineers received FDA clearance for MAGNETOM Free.Max Dental Edition, the first dental dedicated MRI system designed for non ionizing imaging across multiple dental specialties. See our latest analysis for DENTSPLY SIRONA. The FDA clearance comes as DENTSPLY SIRONA’s 1 day share price return of 4.18% contrasts with a weaker 30 day share price return of a 5.64% decline and a 1 year total shareholder return of an...

On March 12, 2026, Calumet, Inc. entered into a Tenth Amendment to its Third Amended and Restated Credit Agreement, allowing the company to issue additional notes and incur more indebtedness under its long-standing facility with Bank of America as administrative agent. This added flexibility to raise debt financing could influence how investors assess Calumet’s balance sheet resilience and its capacity to fund future projects or refinancing efforts. Next, we’ll examine how this expanded...

General Mills (NYSE:GIS) has agreed to sell its Brazil business, including local brands Yoki and Kitano, as part of a portfolio reshaping move. The company is also relaunching its La Tiara taco shells and seasonings nationwide in the U.S., expanding distribution beyond prior regional availability. These actions focus the portfolio on areas where General Mills reports stronger alignment with its priorities and margin goals. General Mills operates across packaged foods categories, with brands...

Astera Labs recently presented at the NVIDIA GTC AI Conference 2026 in San Jose, highlighting its connectivity solutions for AI and cloud infrastructure, while analysts updated research following a newly announced US$6.50 billion warrant agreement with Amazon that ties future equity to long-term collaboration. This combination of a high-profile ecosystem presence and a large warrant-linked partnership with Amazon underscores how central Astera Labs has become to addressing AI server and...

In March 2026, Goldman Sachs issued a flurry of new fixed‑income instruments across a wide range of maturities, while long‑time director Lakshmi Mittal prepared to retire at the 2026 annual meeting under the board’s age-based policy. At the same time, the firm’s commodity and macro research came into sharp focus as its oil shock analysis and recession odds framed investor debate on the Middle East conflict’s global impact. We’ll examine how Goldman’s high-profile oil shock research and macro...

Recent share performance context for Everest Group Everest Group (EG) has drawn investor attention after recent share price moves, with the stock posting a 0.6% gain over the past day but declines over the past week and month. See our latest analysis for Everest Group. At a share price of US$322.50, Everest Group’s recent 1 day share price return contrasts with its weaker year to date share price return of 3.6% and a 1 year total shareholder return decline of 8.1%, suggesting momentum has...

Stoke Therapeutics (STOK) has reported FY 2025 results that feature a wide range of quarterly outcomes. Q1 revenue was US$158.6 million with EPS of US$1.95, followed by Q2 revenue of US$13.8 million and an EPS loss of US$0.40, and Q3 revenue of US$10.6 million with an EPS loss of US$0.65. Over recent periods the company has seen revenue move between US$4.8 million and US$158.6 million per quarter, while EPS has shifted from a US$2.07 loss in FY 2024 to a US$1.95 profit and then back into...

WW International (WW) has just posted its FY 2025 results with Q3 revenue of US$172.1 million and a basic EPS loss of US$1.04, set against a trailing 12 month net income of about US$1.1 billion that reflects a large one off gain. Over recent quarters the company has seen revenue move between US$184.4 million and US$202.1 million, while EPS has swung from a profit of US$0.31 to a loss of US$0.91 and then a very large profit of US$15.71. This pattern points to margins that appear to be heavily...

Doximity (DOCS) is back in focus after releasing a new report showing that 94% of U.S. physicians are using or considering artificial intelligence tools in clinical practice, with broad applications across clinical and administrative tasks. See our latest analysis for Doximity. Despite the excitement around its AI report, Doximity’s share price tells a different story, with a 1 day share price return of 1.30%, a 90 day share price return showing a 43.01% decline, and a 1 year total...

SEALSQ (LAES) has agreed to raise about US$125 million through a registered direct offering of ordinary shares and warrants. The funding move is aimed at liquidity and the commercial rollout of its post quantum and quantum technologies. See our latest analysis for SEALSQ. The follow on offering headlines a busy month for SEALSQ, which also outlined new quantum resilient security products and extended its collaboration with Parrot. However, the share price performance has been weak, with a 7...

If you are wondering whether Babcock & Wilcox Enterprises at around US$14.90 still offers value or if the opportunity has passed, the key is to look closely at what the current price really implies. The stock has recorded a 6.1% return over the past week, 52.8% over the last 30 days and 134.6% year to date, with a very large 1 year return figure that may have shifted how the market views its risk and reward profile. Recent headlines have focused on Babcock & Wilcox Enterprises as part of...

Stagwell (STGW) has put a fresh financing option on the table, filing a US$125.4 million shelf registration for up to 20,000,000 Class A shares tied to an ESOP related offering. See our latest analysis for Stagwell. That shelf filing comes shortly after Stagwell reported fourth quarter and full year 2025 results and completed a sizable buyback program. The stock has gained a 23.1% 30 day share price return to US$6.07, even though the 1 year total shareholder return is roughly flat and the 3...

In recent days, Accenture completed the acquisition of UK-based AI firm Faculty, expanded partnerships with Databricks and Google Cloud, joined a new Torus defence supply chain alliance, and was named the Official Business and Technology Consulting Partner of The R&A through 2031. Together these moves deepen Accenture’s AI and data capabilities across sectors from retail to defence and sport, while concentrating technical leadership in its new chief technology officer, Faculty co-founder Dr...

Alibaba Group Holding (NYSE:BABA) has reorganized its AI operations around a new enterprise-focused unit called Alibaba Token Hub. The company is rolling out agentic AI platforms for businesses, including a new system called Wukong, and plans to plug these agents into services such as Taobao and Alipay. This realignment is being driven by CEO Eddie Wu as Alibaba looks to coordinate its AI products and pursue new monetization opportunities across its ecosystem. Alibaba Group Holding now...

Understanding nCino after a prolonged share price slide nCino (NCNO) has seen its share price weaken over the past year, with negative returns over the past month, past 3 months, and year, putting its current US$15.23 level in focus for valuation minded investors. See our latest analysis for nCino. The recent 40.0% three-month share price decline and 38.2% year-to-date share price return reflect fading momentum, while the 46.6% one-year total shareholder return loss highlights how prolonged...

Capital One Financial (COF) is in focus after a proposed class action settlement on its 360 Savings accounts and fresh commentary from management on integrating Discover Financial and Brex within a digital-first growth plan. See our latest analysis for Capital One Financial. Despite the legal settlement headlines and management’s confidence around integrating Discover and Brex, the share price has slipped recently. The 30-day share price return is 11.55% and the 90-day share price return is...

Morgan Stanley (MS) recently limited investor withdrawals from its North Haven Private Income Fund, honoring 45.8% of redemption requests. This move spotlights liquidity pressures in private credit funds during periods of heavier outflows. See our latest analysis for Morgan Stanley. Recent gating of the North Haven Private Income Fund comes as Morgan Stanley’s share price, last closing at US$157.83, posts a 1 day share price return of 1.37% alongside a 30 day share price return of 7.78% and a...

Earlier this week, Savers Value Village reported preliminary fourth-quarter results showing an 8.8% rise in U.S. comparable sales and 0.7% growth in Canada, while President and COO Jubran N. Tanious exercised options for 100,000 shares at US$1.41 and sold 45,000 shares for about US$373,644 on March 11, 2026. This combination of stronger U.S. store performance and fresh insider share activity offers investors new information on both operational momentum and executive incentives. We’ll now...

Q3 2026 snapshot: Value Line (VALU) leans on margins as earnings trends soften Value Line (VALU) has just reported its Q3 2026 results, with recent quarters showing revenue around US$8.6 million and basic EPS between US$0.42 and US$0.69, while trailing twelve month EPS sits a little above US$2.25. Over the last six reported quarters, revenue has ranged from US$8.39 million to US$8.97 million and basic EPS has moved between US$0.42 and US$0.69, setting up a picture where high profitability...

Coya Therapeutics (COYA) has released its FY 2025 results, reporting fourth quarter revenue of US$4.0 million and a basic EPS loss of US$0.34, alongside trailing twelve month revenue of US$7.9 million and a basic EPS loss of US$1.27. The company’s revenue increased from US$0.00 million in the third quarter of 2024 to US$3.6 million in the third quarter of 2025, while quarterly basic EPS has ranged from a loss of US$0.44 in the first quarter of 2025 to a loss of US$0.13 in the third quarter of...

Zomedica (OTCPK:ZOMD.F) has reported its FY 2025 third quarter with total revenue of US$8.1 million and a basic EPS loss of US$0.006, alongside a net loss of US$6.1 million. Over recent quarters, revenue has moved from US$6.1 million in Q2 2024 to US$6.5 million in Q1 2025 and US$8.1 million in Q3 2025, while quarterly net losses have ranged from US$6.1 million to US$63.8 million and trailing twelve month revenue has reached US$29.5 million against a trailing net loss of US$84.5 million. For...

BlackRock (NYSE:BLK) limited withdrawals from its HPS Corporate Lending Fund (HLEND) for the first time, capping redemptions at 5% of total shares. The move comes as HLEND faces rising redemption pressure in a challenging private credit environment. A securities fraud investigation has been opened into whether BlackRock and certain officers engaged in unlawful business practices. Similar withdrawal restrictions at other private credit managers point to broader funding and liquidity stress...